Skip to content

A safety study of PF-08046044/SGN-35C in adults with advanced cancers

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-505813-26-00
Acronym
C5801001/SGN35C-001
Enrollment
48
Registered
2024-07-30
Start date
2024-09-12
Completion date
Unknown
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaplastic, Diffuse, Hodgkin Disease, Large B-Cell, Large-Cell, Lymphoma, Peripheral, T-Cell

Interventions

None listed

Sponsors

Seagen Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Denmark, France, Germany, Italy, Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026